Micardis 01
Chemical structure of telmisartan, the active ingredient in Micardis HCT tablets containing telmisartan and hydrochlorothiazide.*
Micardis Hct Tablet
Product Images NDC 0597-0043
9 FDA label images from Boehringer Ingelheim Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Micardis Hct (NDC 0597-0043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Micardis 02
Chemical structure of telmisartan and hydrochlorothiazide shown as a molecular formula diagram with labeled atoms and bonds, representing the active ingredients in Micardis HCT tablets.*
Micardis 03
Micardis 04
An instructional illustration showing a hand pressing a tablet through the foil backing of a blister pack containing round tablets. The image demonstrates how to properly remove a tablet from the blister packaging.*
Micardis 05
An instructional diagram showing a hand peeling back a protective foil or film from a product package, demonstrating how to open it.*
Micardis 06
An instructional illustration showing a hand pressing down on a tablet bottle cap while simultaneously turning it to open, demonstrating a safety child-resistant cap removal method.*
Micardis 07
Packaging label for Micardis HCT 40 mg/12.5 mg tablets. Each tablet contains 40 mg telmisartan and 12.5 mg hydrochlorothiazide. The label indicates a package of 30 tablets, arranged as 3 blister cards of 10 tablets each. Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., with dosage and storage instructions included.*
Micardis 08
Packaging label for Micardis HCT 80 mg/12.5 mg tablets, containing telmisartan and hydrochlorothiazide. The label indicates prescription use only and provides details on packaging as 30 tablets in 3 blister cards of 10 tablets each. The labeler is Boehringer Ingelheim Pharmaceuticals, Inc. Warnings include storage and moisture sensitivity instructions. The label has the NDC 0597-0044-37 and includes a barcode and company logo.*
Micardis 09
Micardis HCT 80 mg/25 mg tablets packaging label by Boehringer Ingelheim Pharmaceuticals. Each tablet contains 80 mg of telmisartan and 25 mg of hydrochlorothiazide. The label states this is a human prescription drug with 30 tablets per package, divided into 3 blister cards of 10 tablets each. Dosage and safety instructions are also included.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
